We're currently tracking Baxter FloSeal in the blood/tissue bank. FloSeal is considered a blood derivative by the FDA. We want to transfer oversight of this product to the OR. The standards interpretation group from TJC indicated that compliance surveys are based on the department which is managing them and if OR was managing this product they would need to follow: TJC Laboratory standard QSA.05.01.01 and AABB standards 5.1.6 and 6.2.3. We're not TJC accredited, so I was hoping someone would be willing to share a copy of that particular standard. Thanks!